Discussion about the presentation: "Giant Cell Arteritis: from pathogenesis to new therapeutic targets"

被引：0
|
作者：
Samson, M. [1 ,2 ]
机构：
[1] CHU Dijon Bourgogne, Hop Francois Mitterrand, Serv Med Interne & Immunol Clin, 2 Blvd Lattre Tassigny, F-21000 Dijon, France
[2] Univ Bourgogne Franche Comte, INSERM, EFS BFC, UMR1098, F-21000 Dijon, France
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2020年 / 204卷 / 01期
关键词：
VARICELLA-ZOSTER-VIRUS; POLYMYALGIA-RHEUMATICA; COMPLICATIONS;
D O I：
10.1016/j.banm.2019.11.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：53 / 57
页数：5
相关论文
共 50 条
  • [41] Highlights in clinical medicine—Giant cell arteritis, polymyalgia rheumatica and Takayasu’s arteritis: pathogenic links and therapeutic implications
    Antonio Giovanni Solimando
    Angelo Vacca
    Franco Dammacco
    Clinical and Experimental Medicine, 2022, 22 : 509 - 518
  • [42] A very late presentation of polymyalgia rheumatica in a patient with giant cell arteritis: recurrence or casual association?
    Florez, Helena
    Prieto-Gonzalez, Sergio
    Espigol-Frigole, Georgina
    Cid, Maria C.
    Hernandez-Rodriguez, Jose
    MODERN RHEUMATOLOGY CASE REPORTS, 2019, 3 (02) : 130 - 133
  • [43] Giant cell arteritis (temporal arteritis): A report of four cases from north east India
    Laldinpuii, Judy
    Sanchetee, Pratap
    Borah, Adityendra Lal
    Ghose, Manash
    Borah, Nomal Chandra
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2008, 11 (03) : 185 - 189
  • [44] Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New Zealand
    Lyne, Suellen A. A.
    Ruediger, Carlee
    Lester, Susan
    Chapman, Peter T. T.
    Shanahan, Ernst Michael
    Hill, Catherine L.
    Stamp, Lisa
    FRONTIERS IN MEDICINE, 2022, 9
  • [45] Pathogenesis of giant-cell arteritis: how targeted therapies are influencing our understanding of the mechanisms involved
    Terrades-Garcia, Nekane
    Cid, Maria C.
    RHEUMATOLOGY, 2018, 57 : 51 - 62
  • [46] Highlights in clinical medicine-Giant cell arteritis, polymyalgia rheumatica and Takayasu's arteritis: pathogenic links and therapeutic implications
    Solimando, Antonio Giovanni
    Vacca, Angelo
    Dammacco, Franco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 22 (04) : 509 - 518
  • [47] The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
    Conticini, Edoardo
    Sota, Jurgen
    Falsetti, Paolo
    Baldi, Caterina
    Bardelli, Marco
    Bellisai, Francesca
    Tosi, Gian Marco
    Frediani, Bruno
    Cantarini, Luca
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [48] Giant cell arteritis: insights from a monocentric retrospective cohort study
    Alnaimat, Fatima
    Alduradi, Hamza
    Al-Qasem, Soud
    Ghazzal, Hamza
    Alsarhan, Moath
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (06) : 1013 - 1023
  • [49] Pericarditis among giant cell arteritis patients: From myth to reality
    Tiosano, Shmuel
    Adler, Yehuda
    Azrielant, Shir
    Yavne, Yarden
    Gendelman, Omer
    Shor, Dana Ben-Ami
    Comaneshter, Doron
    Shalom, Guy
    Cohen, Arnon D.
    Amital, Howard
    CLINICAL CARDIOLOGY, 2018, 41 (05) : 623 - 627
  • [50] Projected Worldwide Disease Burden from Giant Cell Arteritis by 2050
    De Smit, Elisabeth
    Palmer, Andrew J.
    Hewitt, Alex W.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (01) : 119 - 125
12345